These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
05 Nov, 2026, 11.49 AM IST
He lost the governor’s primary, then got picked as a last-minute replacement with 566 of 571 votes; 100 days later Troy Jackson unseated Susan CollinsTroy Jackson's political journey took an unexpected turn when he received the Democratic Senate nomination. After Graham Platner withdrew d...
04 Nov, 2026, 11.28 PM IST
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
31 Oct, 2026, 11.47 PM IST
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhen a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...
28 Oct, 2026, 11.11 PM IST
Cipla sets sights on first-wave gains from rollout of Keytruda BiosimilarCipla has partnered with Qilu Pharmaceutical to commercialize a biosimilar of Keytruda, which is a major cancer treatment. The patent for t...
28 Oct, 2026, 01.31 AM IST
China won’t stop its AI from going global, but it wants control over how it travelsProposed rules from China have raised concerns that it could make it harder for its AI companies to take their models overseas, at a time w...
24 Oct, 2026, 04.02 PM IST
AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered a collaboration with insitro to explore new treatment options for challenging liver and heart diseases. The partner...
16 Oct, 2026, 12.53 AM IST
AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered into a partnership with insitro to identify treatments for challenging liver and heart diseases. This collaboration...
15 Oct, 2026, 04.00 PM IST
Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launchBiocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...
15 Oct, 2026, 07.21 AM IST
Biocon clears path for cancer drug launchBiocon has finalized a global settlement and license agreement with Genentech for its drug Pebrilzo. This agreement addresses all ongoing l...
15 Oct, 2026, 12.24 AM IST
Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
14 Oct, 2026, 12.32 AM IST
Existential threats join bubble fears as AI mood sobers at Singapore forumsDuring conferences in Singapore, significant apprehensions regarding the dangers of artificial intelligence emerged among investors and pol...
07 Oct, 2026, 05.47 PM IST
When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
07 Oct, 2026, 05.28 PM IST
Global Market: Hong Kong stocks rise as pharma, tech shares lead gainsHong Kong stocks gained on Tuesday, led by pharmaceutical and technology shares, with the Hang Seng rising 0.78% and Hang Seng Tech Index a...
06 Oct, 2026, 11.08 AM IST
Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
05 Oct, 2026, 05.59 PM IST
ET Business Excellence & Leadership Summit 2026: Celebrating visionaries redefining growth & leadershipThe ET Business Excellence & Leadership Summit 2026 brought together leaders to discuss brand development, innovation, and sustainability. ...
02 Oct, 2026, 10.39 PM IST
Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
22 Sep, 2026, 12.05 AM IST